Find solutions
- Business challenges
- Clinical stages
- Therapeutic area expertise
- About
- Services and capabilities
- PAREXEL Consulting
- Early Phase
- Patient recruiting
- Strategic locations
- Dedicated therapeutic expertise
- Phase I, First in Man
- Phase IIa, Proof of Concept
- Bioanalytical and biomarker
- Bioequivalence services
- Program management
- Ethnobridging
- Case studies
- First Time in Human Study with a Monoclonal Antibody
- Epilepsy Patients with Partial-Onset Seizures
- Healthy Normal Japanese - Ethnobridging
- First Time in Man (FTiM)
- First-in-Man Anesthesia Study – Arterial Sampling
- First-in-Man Study – Psoriasis Patients
- Coronary Heart Disease
- Capsaicin Flare, Heat & Mechanical Pain Perception Threshold
- Moderate to Severe COPD
- PET Receptor Occupancy
- Proof of Concept PET Study
- QTc study (2)
- QT/QTc – Cardiac Repolarisation
- Respiratory Study – sGAW & FEV1
- Adult Schizophrenia Patients
- Patients with Diabetes (NIDDM)
- Volunteer to participate
- Clinical Research
- Late Phase
- Medical Communications
- Technology
- Careers
- Investors
- Reference library
- News and events
- Events
- 2010
- 9th International Congress on Systemic Lupus Erythematosus
- Partnerships in Clinical Trials Latin America
- DIA Clinical Forum
- Partnerships in Clinical Trials Asia-Pacific
- ICAD 2010
- China Clinical Trials Outsourcing
- Partnerships in Clinical Trials Europe
- 13th Registries and Post-Approval Studies Congress
- Late Phase Drug Development World Europe
- ACR/ARHP Annual Scientific Meeting 2010
- Advancing Clinical Trials In Oncology
- Clinical Trials Supply China
- From Asia to the World—Global Integration of Clinical Research
- Achieving Operational Efficiency in Clinical Trials
- MassBioEd Foundation 16th Annual Golf Classic
- 2009
- 2010
- Webcasts
- Insights
- PAREXEL News
- Awards
- Events
- Privacy policy
- Contacts
- Ask An Expert
- Investigator Recruitment
ShareAbout PAREXEL
PAREXEL is a leading global bio/pharmaceutical services organization that helps clients expedite time-to-market through our development and launch services. These include a broad range of clinical development capabilities, integrated advanced technologies, regulatory affairs consulting, and commercialization services.
About |
Services and capabilities |
Clinical stages |
Therapies |
Technology |
Business Challenges |
© Copyright 2000-2010 PAREXEL International |
Tel: +1 781 487 9900 |
Contact Us |
Privacy Policy
View site index